Clinical trial
A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients
NCT01426789
Study timeline
Study start (unknown)2011-08-01Date precision: month
Registry last updated2015-08-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
PlaceboDRUG
SecukinumabDRUG · verified · RxNorm: secukinumab
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01426789 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.